Jubilant Pharmova Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.89 per cent from ₹2,122.50 crore. This corresponds to a year-on-year *(YoY) growth of 18.73 per cent.
Operating Profit
Operating Profit stands at ₹325.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 30.40 per cent from ₹249.70 crore. This corresponds to a year-on-year *(YoY) decline of 4.80 per cent.
PBDT
PBDT stands at ₹292.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 36.76 per cent from ₹214.10 crore. This corresponds to a year-on-year *(YoY) decline of 2.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹176.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 88.44 per cent from ₹93.40 crore. This corresponds to a year-on-year *(YoY) decline of 14.56 per cent.
Net Profit
Net Profit stands at ₹119.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 113.80 per cent from ₹55.80 crore. This represents a 21.15 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Jubilant Pharmova Ltd News
Jubilant Pharmova Ltd Earnings
- YOY
- QOQ
Jubilant Pharmova Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Jubilant Pharmova Ltd Research Reports
Jubilant Pharmova Ltd Financial Reports
Jubilant Pharmova Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Jubilant Pharmo | -0.40% | 1.25% | 0.05% | 4.69% | 0.90% | -18.36% |
| Natco Pharma | -0.27% | 1.60% | 1.12% | -15.99% | 14.34% | -1.91% |
| Cohance Life | -0.70% | 2.25% | -5.38% | -9.14% | 15.41% | -57.19% |
| Alembic Pharma | -1.04% | 0.83% | -2.95% | 5.00% | 2.25% | -17.87% |
| Concord Biotech | 0.16% | 7.17% | 4.00% | 11.97% | 17.37% | -24.42% |
| Alivus Life | -1.51% | 1.01% | -1.90% | 4.20% | 21.54% | 8.00% |
| Corona Remedies | 0.41% | -0.39% | 7.41% | 21.64% | 45.46% | 46.53% |
Company Info
Company Information
Chairman (Non-Executive) : Shyam S Bhartia
Co-Chairman : Hari S Bhartia
Independent Director : Vivek Mehra
Independent Director : SUSHIL KUMAR ROONGTA
Managing Director : Priyavrat Bhartia
Joint Managing Director : Arjun Shanker Bhartia
Independent Director : Arun Seth
Independent Director : Shirish Gundopant Belapure
Whole-time Director : Ramakrishnan Arul
Independent Director : Harsh Mahajan
Independent Director : Shivpriya Nanda
Whole Time Director : Arvind Chokhany
Company Sec. & Compli. Officer : Naresh Kapoor.